Improving antibiotic prescribing for children in the resource-poor setting

Kirsty Le Doare1, Charlotte I S Barker, Adam Irwin

  • 1Paediatric Infectious Diseases Research Group, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK; Wellcome Trust Centre for Global Health Research, Imperial College, Norfolk Place, London, W2 1NY, UK.

Insights

Antibiotic use in low- and middle-income countries (LMICs) is vital for child health but often inappropriate. Improving prescribing practices requires better access to medicines and evidence-based guidelines to combat antimicrobial resistance.

Area of Science:

  • Global Health
  • Pediatric Pharmacology
  • Antimicrobial Stewardship

Background:

  • Antibiotics are essential for treating infectious diseases, the primary cause of mortality in children in low- and middle-income countries (LMICs).
  • Inappropriate antibiotic use, including incorrect prescribing and patient adherence, is widespread globally, contributing to antimicrobial resistance.
  • LMICs face significant challenges in implementing policies for rational antibiotic use in pediatric care.

Purpose of the Study:

  • To provide an overview of the challenges and strategies for rational antibiotic prescribing in pediatric populations within LMICs.
  • To highlight the impact of inappropriate antibiotic use on antimicrobial resistance and child mortality.
  • To discuss future developments that could enhance antibiotic prescribing in LMICs.

Main Methods:

  • Review of existing literature and World Health Organization (WHO) initiatives related to pediatric medicine use in LMICs.
  • Analysis of barriers to rational antibiotic prescribing in resource-limited settings.
  • Discussion of strategies for improving access to appropriate medications and clinical guidelines.

Main Results:

  • Inappropriate antibiotic use is a major concern in LMICs, exacerbating antimicrobial resistance.
  • WHO initiatives like 'Make medicines child size' are crucial steps but require continued support.
  • Persistent barriers hinder the effective implementation of rational prescribing policies.

Conclusions:

  • Improving access to appropriate pediatric formulations and strengthening evidence-based guidelines are essential for rational antibiotic use in LMICs.
  • Addressing inappropriate antibiotic use is critical to combatting antimicrobial resistance and reducing child mortality.
  • Future developments must focus on sustainable strategies to enhance pediatric antibiotic prescribing in resource-limited settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Antibiotic Selection00:57

Antibiotic Selection

Overview
48.9K